Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells is Associated with a Good Prognosis and Infiltrating Lymphocytes

Triple negative breast cancer (TNBC) is a subtype with heterogeneous patient outcomes. Approximately forty percent of patients experience rapid relapse, while the remaining patients have long-term disease-free survival. To determine if there are molecular differences between primary tumors that pred...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Immunol Res
Auteurs principaux: Forero, Andres, Li, Yufeng, Chen, Dongquan, Grizzle, William E., Updike, Katherine L., Merz, Natalie D., Downs-Kelly, Erinn, Burwell, Todd C., Vaklavas, Christos, Buchsbaum, Donald J., Myers, Richard M., LoBuglio, Albert F., Varley, Katherine E.
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4878913/
https://ncbi.nlm.nih.gov/pubmed/26980599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-15-0243
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires